|
by Banerjee, Srabani, Argáez, Charlene
Published 2017
Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Subramonian, Anusree, Argáez, Charlene
Published 2020
Published 2020
Canadian Agency for Drugs and Technologies in Health
|
by Gray, Casey, Argáez, Charlene
Published 2020
Published 2020
Canadian Agency for Drugs and Technologies in Health
|
by Tran, Khai, Argáez, Charlene
Published 2017
Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Yeung, Shirley S. T., Argáez, Charlene
Published 2017
Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, Argáez, Charlene
Published 2017
Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Poitras, Veronica, Argáez, Charlene
Published 2017
Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Thompson, Wade, Argáez, Charlene
Published 2019
Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Dulong, Camille, Brett, Kendra, Argáez, Charlene
Published 2020
Published 2020
Canadian Agency for Drugs and Technologies in Health
|
by Thompson, Wade, Argáez, Charlene
Published 2020
Published 2020
Canadian Agency for Drugs and Technologies in Health
|
by Lachance, Chantelle, Argáez, Charlene
Published 2019
Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Majid, Umair, Argáez, Charlene
Published 2020
Published 2020
Canadian Agency for Drugs and Technologies in Health